Skip to content
You are now leaving to visit

Biogen and Ionis Expand Strategic Collaboration to Develop Drug Candidates for a Broad Range of Neurological Diseases

Transaction builds upon the productive collaboration that produced SPINRAZA ®  as well as two antisense drug candidates currently in the clinic, with the potential to advance up to seven more drug candidates to the clinic within the next two years The antisense platform developed by Ionis is an